Sotera Health Company SHC
$ 13.43
1.21%
Quarterly report 2024-Q3
added 11-05-2024
Sotera Health Company Balance Sheet 2011-2024 | SHC
Annual Balance Sheet Sotera Health Company
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
1.93 B | 1.36 B | 1.65 B | 1.72 B | 2.75 B | 2.11 B | - | - | - | - | - | - | - |
Long Term Debt |
2.22 B | 1.75 B | 1.74 B | 1.82 B | 2.8 B | 2.19 B | - | - | - | - | - | - | - |
Long Term Debt Current |
5.93 M | 7.55 M | 9.29 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 3.1 B | 2.52 B | - | - | - | - | - | - | - |
Total Current Liabilities |
231 M | 792 M | 161 M | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.69 B | 2.77 B | 2.2 B | 2.31 B | 3.22 B | 2.66 B | - | - | - | - | - | - | - |
Deferred Revenue |
13.5 M | 12.1 M | 8.67 M | 6.06 M | 3.63 M | 4.62 M | - | - | - | - | - | - | - |
Retained Earnings |
-654 M | -706 M | -472 M | -589 M | -551 M | -10.4 M | - | - | - | - | - | - | - |
Total Assets |
3.13 B | 3.12 B | 2.79 B | 2.76 B | 2.58 B | 2.71 B | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
296 M | 395 M | 107 M | 102 M | - | - | - | - | - | - | - | - | - |
Book Value |
444 M | 350 M | 586 M | 455 M | -641 M | 45.5 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
444 M | 350 M | 586 M | 455 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Sotera Health Company
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.21 B | 2.21 B | 2.22 B | 2.22 B | 2.22 B | 2.22 B | 1.75 B | 1.75 B | - | 1.74 B | 1.74 B | 1.74 B | 1.84 B | 1.84 B | 1.82 B | 1.82 B | 1.82 B | 34.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.68 B | 2.64 B | 2.63 B | 2.66 B | 2.66 B | 3.05 B | 2.77 B | 2.2 B | - | 2.19 B | 2.2 B | 2.22 B | 2.33 B | 2.31 B | 2.31 B | 2.31 B | 2.31 B | 2.31 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
10.7 M | 13 M | 12.9 M | 12.7 M | 13.8 M | 15.2 M | 12.1 M | 5.35 M | - | 12.9 M | 8.67 M | 4.87 M | 5.54 M | 5.96 M | 6.06 M | 6.06 M | 6.06 M | 6.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-622 M | -639 M | -648 M | -693 M | -679 M | -703 M | -706 M | -386 M | - | -442 M | -472 M | -508 M | -536 M | -578 M | -589 M | -589 M | -589 M | -589 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
3.15 B | 3.06 B | 3.06 B | 3.04 B | 3.07 B | 3.41 B | 3.12 B | 2.81 B | - | 2.84 B | 2.79 B | 2.74 B | 2.85 B | 2.78 B | 2.76 B | 2.76 B | 2.76 B | 2.76 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
307 M | 246 M | 261 M | 253 M | 270 M | 660 M | 395 M | 165 M | 141 M | 121 M | 107 M | 115 M | 156 M | 108 M | 102 M | 102 M | 102 M | 102 M | 63 M | - | - | - | 96.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
470 M | 423 M | 429 M | 377 M | 418 M | 361 M | 350 M | 607 M | - | 642 M | 586 M | 526 M | 523 M | 466 M | 455 M | 455 M | 455 M | 455 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
470 M | 423 M | 429 M | 377 M | 418 M | 361 M | 350 M | 607 M | 636 M | 642 M | 586 M | 526 M | 523 M | 463 M | 452 M | 452 M | 452 M | 452 M | -641 M | - | - | - | 45.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency